Published in Proc Natl Acad Sci U S A on February 20, 1996
Mechanisms for T cell receptor triggering. Nat Rev Immunol (2010) 2.30
In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A (2000) 1.92
Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J Biol Chem (2005) 1.92
T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes. J Exp Med (2005) 1.69
Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med (1997) 1.51
T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49
Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat Rev Immunol (2009) 1.49
Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med (1996) 1.48
DNA specificity enhanced by sequential binding of protein monomers. Proc Natl Acad Sci U S A (1999) 1.48
Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc Natl Acad Sci U S A (1999) 1.47
Concern Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy. Front Immunol (2013) 1.41
Ligand-receptor kinetics measured by total internal reflection with fluorescence correlation spectroscopy. Biophys J (2003) 1.39
CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J Exp Med (2001) 1.38
A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. J Exp Med (1999) 1.36
Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med (1996) 1.36
Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol (2009) 1.36
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci U S A (2001) 1.31
Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor. Proc Natl Acad Sci U S A (2001) 1.30
Structural and biophysical determinants of αβ T-cell antigen recognition. Immunology (2012) 1.30
Stochastic effects and bistability in T cell receptor signaling. J Theor Biol (2008) 1.17
CD8 controls T cell cross-reactivity. J Immunol (2010) 1.15
T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs. J Exp Med (1999) 1.15
Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Protein Sci (1999) 1.14
Cooperative enhancement of specificity in a lattice of T cell receptors. Proc Natl Acad Sci U S A (2001) 1.13
Breaking the affinity ceiling for antibodies and T cell receptors. Proc Natl Acad Sci U S A (2000) 1.12
Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol (2007) 1.08
Direct single molecule measurement of TCR triggering by agonist pMHC in living primary T cells. Elife (2013) 1.04
A logical analysis of T cell activation and anergy. Proc Natl Acad Sci U S A (1999) 1.03
Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. J Exp Med (1997) 1.01
Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex. Biophys J (2008) 1.00
Immunology and mathematics: crossing the divide. Immunology (2005) 0.98
The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology (2007) 0.98
A role for CD8 in the developmental tuning of antigen recognition and CD3 conformational change. J Immunol (2008) 0.97
Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc Natl Acad Sci U S A (1998) 0.96
Ligand detection and discrimination by spatial relocalization: A kinase-phosphatase segregation model of TCR activation. Biophys J (2006) 0.95
The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy. Front Immunol (2012) 0.94
Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology. Front Immunol (2013) 0.93
Total internal reflection with fluorescence correlation spectroscopy: nonfluorescent competitors. Biophys J (2004) 0.93
T cell sensitivity and the outcome of viral infection. Clin Exp Immunol (2009) 0.92
2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system. Eur J Immunol (2013) 0.92
Epitope flexibility and dynamic footprint revealed by molecular dynamics of a pMHC-TCR complex. PLoS Comput Biol (2012) 0.91
Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes. AIDS (2010) 0.91
Mechanical regulation of T-cell functions. Immunol Rev (2013) 0.91
T cell antigen recognition at the cell membrane. Mol Immunol (2012) 0.90
Insights from in situ analysis of TCR-pMHC recognition: response of an interaction network. Immunol Rev (2013) 0.90
Superantigens: just like peptides only different. J Exp Med (1998) 0.89
Altered hapten ligands antagonize trinitrophenyl-specific cytotoxic T cells and block internalization of hapten-specific receptors. J Exp Med (1997) 0.89
Determination of interaction kinetics between the T cell receptor and peptide-loaded MHC class II via single-molecule diffusion measurements. Biophys J (2012) 0.88
High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics. Mol Immunol (2010) 0.87
Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor. Eur J Immunol (2007) 0.87
Suboptimal engagement of the T-cell receptor by a variety of peptide-MHC ligands triggers T-cell anergy. Immunology (2009) 0.87
Engineering improved T cell receptors using an alanine-scan guided T cell display selection system. J Immunol Methods (2013) 0.85
T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC. Proc Natl Acad Sci U S A (2009) 0.85
Transient alteration of T cell fine specificity by a strong primary stimulus correlates with T cell receptor down-regulation. Eur J Immunol (1998) 0.85
Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation. Proc Natl Acad Sci U S A (2002) 0.85
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope. Mol Immunol (2005) 0.84
Role of CD8 in aberrant function of cytotoxic T lymphocytes. J Exp Med (1997) 0.82
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
T-cell activation: A queuing theory analysis at low agonist density. Biophys J (2006) 0.82
Cellular-level versus receptor-level response threshold hierarchies in T-cell activation. Front Immunol (2013) 0.81
Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide. Proc Natl Acad Sci U S A (1998) 0.79
Modeling the T cell immune response: a fascinating challenge. J Pharmacokinet Pharmacodyn (2014) 0.77
Clonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligand. Immunology (2001) 0.77
Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain. J Exp Med (1999) 0.75
Signaling cascades: escape from kinetic proofreading. Proc Natl Acad Sci U S A (2001) 0.75
Early T-cell activation biophysics. HFSP J (2009) 0.75
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells. Cancer Immunol Immunother (2017) 0.75
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell (1994) 27.85
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proc Natl Acad Sci U S A (1974) 9.17
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 5.01
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature (1990) 4.59
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (1994) 4.42
The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (1990) 4.09
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature (1994) 3.97
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature (1992) 3.36
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (1994) 2.81
Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity (1994) 2.39
CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 2.15
Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (1991) 2.11
ZAP-70 is constitutively associated with tyrosine-phosphorylated TCR zeta in murine thymocytes and lymph node T cells. Immunity (1994) 1.88
T cell receptor antagonists and partial agonists. Immunity (1995) 1.83
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem Sci (1994) 1.82
Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu Rev Immunol (1994) 1.73
Specificity and flexibility in thymic selection. Nature (1994) 1.72
Functional consequences of engagement of the T cell receptor by low affinity ligands. J Immunol (1993) 1.70
Ligands for the T-cell receptor: hard times for avidity models. Immunol Today (1995) 1.46
Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc Natl Acad Sci U S A (1993) 1.21
Positive selection of CD4+ T cells by TCR ligation without aggregation even in the absence of MHC. Nature (1994) 1.21
Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc Natl Acad Sci U S A (1994) 1.20
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J Exp Med (1994) 1.19
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity (1994) 1.10
Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays. J Exp Med (1992) 0.92
T-cell receptors. Serial engagement proposed. Nature (1995) 0.88
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (1989) 9.01
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature (1984) 8.89
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc (1971) 7.23
Lateral phase separation in phospholipid membranes. Biochemistry (1973) 6.56
Determination of molecular motion in membranes using periodic pattern photobleaching. Proc Natl Acad Sci U S A (1978) 6.35
Supported phospholipid bilayers. Biophys J (1985) 6.18
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (1984) 6.08
Allogeneic stimulation of cytotoxic T cells by supported planar membranes. Proc Natl Acad Sci U S A (1984) 5.69
Spin-labeled biomolecules. Proc Natl Acad Sci U S A (1965) 5.41
Inside-outside transitions of phospholipids in vesicle membranes. Biochemistry (1971) 4.84
Supported planar membranes in studies of cell-cell recognition in the immune system. Biochim Biophys Acta (1986) 4.83
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell (1994) 4.60
Spin-label studies of the excitable membranes of nerve and muscle. Proc Natl Acad Sci U S A (1968) 4.58
The immunological synapse. Annu Rev Immunol (2001) 4.45
Lateral diffusion in binary mixtures of cholesterol and phosphatidylcholines. Proc Natl Acad Sci U S A (1979) 4.26
Somatic recombination in a murine T-cell receptor gene. Nature (1984) 4.21
Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature (1984) 4.15
Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (1992) 4.01
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science (1998) 3.76
DNA sequences mediating class switching in alpha-immunoglobulins. Science (1980) 3.70
Lateral phase separations in membrane lipids and the mechanism of sugar transport in Escherichia coli. Proc Natl Acad Sci U S A (1973) 3.70
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Cell-type-specific cDNA probes and the murine I region: the localization and orientation of Ad alpha. Proc Natl Acad Sci U S A (1984) 3.43
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature (1988) 3.43
Antigen-specific development of primary and memory T cells in vivo. Science (1995) 3.41
Structural gene sets active in embryos and adult tissues of the sea urchin. Cell (1976) 3.38
CDR3 length in antigen-specific immune receptors. J Exp Med (1994) 3.35
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol (1999) 3.33
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
Differential clustering of CD4 and CD3zeta during T cell recognition. Science (2000) 3.30
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell (1989) 3.29
Phase equilibria in binary mixtures of phosphatidylcholine and cholesterol. Biochemistry (1981) 3.28
A third type of murine T-cell receptor gene. Nature (1984) 3.24
A human T cell-specific molecule is a member of a new gene family. J Immunol (1988) 3.21
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A (1979) 3.19
A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature (1987) 3.08
Lateral diffusion in spin-labeled phosphatidylcholine multilayers. J Am Chem Soc (1972) 3.08
Physical properties of lipid monolayers on alkylated planar glass surfaces. Biophys J (1981) 3.07
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Condensed complexes of cholesterol and phospholipids. Biophys J (1999) 3.01
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
T-cell receptor delta gene rearrangements in early thymocytes. Nature (1988) 2.88
Theoretical study of protein--lipid interactions in bilayer membranes. Proc Natl Acad Sci U S A (1978) 2.86
Antigen presentation by supported planar membranes containing affinity-purified I-Ad. Proc Natl Acad Sci U S A (1984) 2.80
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med (2000) 2.78
Lateral diffusion of phospholipids in a vesicle membrane. Proc Natl Acad Sci U S A (1971) 2.71
Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature (1984) 2.71
Theory of protein-lipid and protein-protein interactions in bilayer membranes. Proc Natl Acad Sci U S A (1979) 2.69
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci U S A (1998) 2.69
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Lateral phase separations in binary mixtures of cholesterol and phospholipids. Biochem Biophys Res Commun (1973) 2.62
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Specific antibody-dependent interactions between macrophages and lipid haptens in planar lipid monolayers. Proc Natl Acad Sci U S A (1981) 2.55
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity (1998) 2.52
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
Stimulation of fluorescence in a small contact region between rat basophil leukemia cells and planar lipid membrane targets by coherent evanescent radiation. J Biol Chem (1982) 2.41
Rapid lateral diffusion of phospholipids in rabbit sarcoplasmic reticulum. Proc Natl Acad Sci U S A (1972) 2.39
Physics and chemistry of spin labels. Q Rev Biophys (1970) 2.35
Anisotropic molecular motion on cell surfaces. Proc Natl Acad Sci U S A (1979) 2.33
Detection of cell-affecting agents with a silicon biosensor. Science (1989) 2.31
Orientation and motion of amphiphilic spin labels in membranes. Proc Natl Acad Sci U S A (1969) 2.29
Condensed complexes, rafts, and the chemical activity of cholesterol in membranes. Proc Natl Acad Sci U S A (2000) 2.26
Electric field-induced concentration gradients in lipid monolayers. Science (1994) 2.24
Antibodies bound to lipid haptens in model membranes diffuse as rapidly as the lipids themselves. Proc Natl Acad Sci U S A (1979) 2.24
Chemical activity of cholesterol in membranes. Biochemistry (2000) 2.21
Structural and dynamical aspects of membrane immunochemistry using model membranes. Biochemistry (1977) 2.17
Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol (1994) 2.15
Glycophorin in lipid bilayers. Proc Natl Acad Sci U S A (1974) 2.11
Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) (2009) 2.09
Two-dimensional chiral crystals of phospholipid. Nature (1984) 2.05
The intermediate monoclinic phase of phosphatidylcholines. Biochim Biophys Acta (1977) 2.00
Identification of self through two-dimensional chemistry and synapses. Annu Rev Cell Dev Biol (2001) 1.99
An alternative view of phospholipid phase behavior at the air-water interface. Microscope and film balance studies. Biophys J (1981) 1.97
Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity (1998) 1.97
Localization of a T-cell receptor diversity-region element. Nature (1984) 1.96
Molecular components of T-cell recognition. Annu Rev Immunol (1992) 1.96
Motion of steroid spin labels in membranes. Proc Natl Acad Sci U S A (1969) 1.94
Regulating the retention of T-cell receptor alpha chain variants within the endoplasmic reticulum: Ca(2+)-dependent association with BiP. J Cell Biol (1991) 1.93
Not without my permission: parents' willingness to permit use of newborn screening samples for research. Public Health Genomics (2009) 1.92
Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med (1991) 1.92
Motion of fatty acid spin labels in the plasma membrane of mycoplasma. Biochim Biophys Acta (1970) 1.91
Lateral diffusion in inhomogeneous membranes. Model membranes containing cholesterol. Biophys J (1980) 1.89
A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature (1989) 1.89
Order in supported phospholipid monolayers detected by the dichroism of fluorescence excited with polarized evanescent illumination. Biophys J (1984) 1.89
T-cell-mediated association of peptide antigen and major histocompatibility complex protein detected by energy transfer in an evanescent wave-field. Nature (1986) 1.88
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
A nitroxide-maleimide spin label. Proc Natl Acad Sci U S A (1966) 1.85
Interactions of proteins and cholesterol with lipids in bilayer membranes. Biochim Biophys Acta (1976) 1.83